Manufactures custom peptides, protein conjugates and liposomes. Includes technology overview, applications, request forms and contacts in North West England.

Company with proprietary technology to enhance half-life and therapeutic efficacy, by fusing bioactive protein sequence to human transferrin, and using yeast host cell expression systems for production. Opportunities and contacts in King of Prussia, Pennsylvania.

Offer novel peptide-based molecules to treat infectious diseases, using technology for design of antibacterial, antifungal, and antiparasitic drugs, bio-pesticides and enhancers for pharmaceuticals. Corporate office in Wayne, Pennsylvania.

Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. Includes technology overview, research pipeline, partnerships, investment news, profiles of key staff in Montreal, Canada.

Developed a proprietary technology to administer large molecule drugs, including hormone proteins, peptides, monoclonal antibodies and vaccines as a mist absorbed in the buccal mucosa. Overview of production, aims and investor data of company in Toronto, Ontario.

Non-viral drug delivery technology based on cationic liposomes, under clinical development for vector systems on license from Imperial College, London, UK.

Offers products for regulated insulin and alpha-interferon, and develops engineered human cells for implanting genes. Includes technology overview and profile of company in Irvine, California.